TE_29515
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1M1_orf2 |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | DNM1P32 |
| Class | Chimeric |
| Coding | Other |
| Tumor-specific score | 0.04 |
| Counts of samples | TCGA_tumor:7; TCGA_normal:0; GTEx:244 |
| TSS | chr15(+):32435817 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_29515.1 | DNM1P32 | Chimeric | Other | METTQNLVDSYMAIVNKTVWDLMTKEFIFSELLSNLYSRGDQKTLMEESAEQAQWRDEMLRMYHVLKEALGIIGNINTTTISTHMGARGQLLPAGAERPCRMQVPRLAPTAPKPPSPHG* | chr15(+):32435818,32436631,32437422,32437724,32439701,32439721 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
